SCHEMBL6664572

SCHEMBL6664572

COc1ccccc1S/C=C/C(N)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.50
ALDH1A1 P00352 2/20 0.50
MAPT P10636 2/20 0.50
GAA P10253 1/20 0.50
NFE2L2 Q16236 2/20 0.42
TFEB P19484 1/20 0.42
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
KDM4E B2RXH2 1/20 0.41
POLB P06746 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
TSHR P16473 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6942168 1.00 HTT (0.50) HTTALDH1A1MAPTGAANFE2L2
SCHEMBL6664578 1.00 HTT (0.50) HTTALDH1A1MAPTGAANFE2L2
SCHEMBL6942137 0.85 SMN1; SMN2 (0.49) HTTALDH1A1MAPTGAANFE2L2
SCHEMBL6942134 0.85 SMN1; SMN2 (0.49) HTTALDH1A1MAPTGAANFE2L2
SCHEMBL7464335 0.78 MAPT (0.38) HTTALDH1A1MAPTGAAPOLB
SCHEMBL12656573 0.73 CA1 (0.48) HTTALDH1A1GAANFE2L2TFEB
1,2-Dimethoxybenzene SCHEMBL28118612 0.72 CA1 (0.72) HTTALDH1A1MAPTGAANFE2L2
SCHEMBL1379749 0.71 NFE2L2 (0.74) ALDH1A1MAPTNFE2L2TFEBKDM4E
SCHEMBL1477685 0.71 NFE2L2 (0.74) ALDH1A1MAPTNFE2L2TFEBKDM4E
SCHEMBL1477777 0.71 NFE2L2 (0.74) ALDH1A1MAPTNFE2L2TFEBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1453828-A2 AZABICYCLIC COMPOUNDS FOR THE TREATMENT OF FIBROMYALGIA SYNDROME AstraZeneca AB (SE) 2004-09-08 EP disclosed
WO-2003032897-A2 AZABICYCLIC COMPOUNDS FOR THE TREATMENT OF FIBROMYALGIA SYNDROME ASTRAZENECA AB (SE) 2003-04-24 WO disclosed